 |
|
|
| |
CARD8 Activation for Reservoir Reduction with Efavirenz (CARRE Trial)
An open-label, single arm trial to assess the safety and efficacy of in vivo CARD8 activation with Efavirenz intensification on HIV-1 reservoir reduction in people living with HIV-1
|
| |
| |
Priya Pal1 Greg Laird2, Ryann Gollings3, Mark A Marzinke3, Andrew Atkinson1,4, Michael J. Peluso5, Steven G. Deeks5, Brittany O. Trudo6, Teresa A. Spitz6, Benjamin S. Strnad7, William D. Middleton7, Leyao Wang8,9, Rachel M. Presti1,6, Liang Shan10
Priya Pal1 Greg Laird2, Ryann Gollings3, Mark A Marzinke3, Andrew Atkinson1,4, Michael J. Peluso5, Steven G. Deeks5, Brittany O. Trudo6, Teresa A. Spitz6, Benjamin S. Strnad7, William D. Middleton7, Leyao Wang8,9, Rachel M. Presti1,6, Liang Shan10
|
| |
|
|
|
|
|
